Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τρίτη 13 Μαρτίου 2018

Simple solution to prevent postoperative bleeding from paramidline forehead flap

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Collin M. Blattner, Brandon Markus, William Lear




http://ift.tt/2GpZgil

Table of Contents

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2Dq4JCO

I pledge to prescribe ethically

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Andrew Kelsey, Justin Finch, Jane M. Grant-Kels




http://ift.tt/2GpZ6HL

Information for Readers

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2FGYJYa

Comorbidities in rosacea: A systematic review and update

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Roger Haber, Maria El Gemayel
BackgroundRosacea is linked to abnormalities of cutaneous vasculature and dysregulation of the inflammatory response. Recent reports on rosacea have shown a significant association with cardiovascular, gastrointestinal, and psychiatric diseases, all of which may affect morbidity and mortality among these patients.ObjectiveTo review available data regarding comorbidities associated with rosacea, discuss their pathogenesis, and highlight the evaluation of affected patients.MethodsWe performed a complete and systematic literature review in PubMed/Medline, Embase, and the Cochrane Collaboration databases, searching for all articles on possible associated diseases that have been reported with rosacea, with no limits on publication date, participant age, sex, or nationality.ResultsA total of 29 studies were included in this systematic review, including 14 case-control, 8 cross-sectional, and 7 cohort studies. Statistically significant association with rosacea has been mostly demonstrated with depression (n = 117,848 patients), hypertension (n = 18,176), cardiovascular diseases (n = 9739), anxiety disorder (n = 9079), dyslipidemia (n = 7004), diabetes mellitus (n = 6306), migraine (n = 6136), rheumatoid arthritis (n = 4192), Helicobacter pylori infection (n = 1722), ulcerative colitis (n = 1424), and dementia (n = 1194).LimitationsLimitations included the accuracy of the published data, potential patient selection, and possible confounding factors. The true nature of the drawn correlations is uncertain, and causality cannot be established.ConclusionsRosacea is associated with a number of systemic disorders. Recognition of these conditions is critical to providing appropriate screening and management of affected patients.



http://ift.tt/2GrvZE7

JAAD Case Reports Article List

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2FHaTAk

Journal Based CME Instructions and Information

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2GqJTGq

Alopecia areata is a medical disease

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Dorota Z. Korta, Angela M. Christiano, Wilma Bergfeld, Madeleine Duvic, Abby Ellison, Jennifer Fu, John E. Harris, Maria K. Hordinsky, Brett King, Dory Kranz, Julian Mackay-Wiggan, Amy McMichael, David A. Norris, Vera Price, Jerry Shapiro, Natasha Atanaskova Mesinkovska




http://ift.tt/2FGpr3s

Analysis of the patient experience measure

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Nicholas Golda, Stephen Beeson, Nita Kohli, Brandon Merrill
Assessing the patient experience has been a component of national health care policy for years in various forms, and it is now incorporated into many areas affecting physician practice. This review will focus on the origin and importance of this measure and address its critiques. The evolution of the measure as it progressed from patient satisfaction to patient experience and the rationale behind this shift will be detailed, the thought process behind the measure as an indicator of a culture of patient-centeredness and quality rather than as strictly a score will be reviewed, and the various motivators for physicians to improve patient experience will be divided into extrinsic and intrinsic and discussed.



http://ift.tt/2GpYNN7

Editorial Board

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2FFeTBj

Answers to CME examination

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2Gpf9FQ

Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: A prospective randomized clinical trial

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Jeong-Wan Seo, Ki-Hoon Song




http://ift.tt/2FGViRw

CME examination

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2GuhOOM

Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Keshavamurthy Vinay, Simone Cazzaniga, Kyle T. Amber, Laurence Feldmeyer, Luigi Naldi, Luca Borradori




http://ift.tt/2FJlZEU

Recommendations for improving the patient experience in specialty encounters

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Nicholas Golda, Stephen Beeson, Nita Kohli, Brandon Merrill
The relationship between patient experience and health care quality has generated significant interest in the patient experience measure. However, it is challenging to find information on how to improve one's patient experience score because scientific data on this topic are weak or lacking, and suggestions provided by scoring vendors are often overgeneralized and not specialty-specific. This review will focus on the current state of evidence supporting factors influencing patient experience (both positive and negative) in outpatient specialist encounters that are applicable to general and surgical dermatology. The literature review includes research from multiple medical specialties. Identified studies were based on title and abstract and sourced from Medline, PubMed, and Scopus databases. Medical subject headings terms in PubMed and Ovid Medline included "dermatology/standards," "patient satisfaction," "surgery/standards," "physician-patient relations," "surgery," "practice management," "practice management, medical," "office management," "patient experience," "practice guidelines," "best practice," and "outpatient surgery." During this review, three main themes affecting the patient experience emerged: communication, time, and access. Of the three, communication appears to be the dominant theme affecting the patient experience measure.



http://ift.tt/2GpzgDN

CME examination

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2FHxRaE

Prescribing to save patients money: Ethical considerations

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Shridat A. Jadoo, Jules B. Lipoff




http://ift.tt/2pcusdy

Answers to CME examination

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4





http://ift.tt/2DrbpQZ

All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Mackenzie R. Wehner, Wilmarie Cidre Serrano, Adi Nosrati, Patrick Michael Schoen, Mary-Margaret Chren, John Boscardin, Eleni Linos
BackgroundThere are varying reports of the association of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) with mortality.ObjectiveTo synthesize the available information on all-cause mortality after a diagnosis of BCC or SCC in the general population.MethodsWe searched PubMed (1966-present), Web of Science (1898-present), and Embase (1947-present) and hand-searched to identify additional records. All English articles that reported all-cause mortality in patients with BCC or SCC were eligible. We excluded case reports, case series, and studies in subpopulations of patients. Random effects model meta-analyses were performed separately for BCC and SCC.ResultsThe searches yielded 6538 articles, and 156 were assessed in a full-text review. Twelve studies met the inclusion criteria, and 4 were included in the meta-analysis (encompassing 464,230 patients with BCC and with 175,849 SCC), yielding summary relative mortalities of 0.92 (95% confidence interval, 0.83-1.02) in BCC and 1.25 (95% confidence interval, 1.17-1.32) in SCC.LimitationsOnly a minority of studies controlled for comorbidities. There was significant heterogeneity in meta-analysis (χ2P < .001, I2 > 98%), but studies of SCC were qualitatively concordant: all showed statistically significant increased relative mortality.ConclusionsWe found that patients with SCC are at higher risk for death from any cause compared with the general population.



http://ift.tt/2pcup1m

Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study

Publication date: April 2018
Source:Journal of the American Academy of Dermatology, Volume 78, Issue 4
Author(s): Thomas B. Casale, Patrick H. Win, Jonathan A. Bernstein, Karin Rosén, Michael Holden, Ahmar Iqbal, Benjamin L. Trzaskoma, Ming Yang, Evgeniya N. Antonova, Thomas Murphy, Mark D. Scarupa, Howard Sofen, Allen Kaplan




http://ift.tt/2DpXYkF

Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress

Publication date: Available online 13 March 2018
Source:Ultrasound in Medicine & Biology
Author(s): Federico Moccetti, Craig C. Weinkauf, Brian P. Davidson, J. Todd Belcik, Edmund R. Marinelli, Evan Unger, Jonathan R. Lindner
The aim of this study was to evaluate a panel of endothelium-targeted microbubble (MB) ultrasound contrast agents bearing small peptide ligands as a human-ready approach for molecular imaging of markers of high-risk atherosclerotic plaque. Small peptide ligands with established affinity for human P-selectin, VCAM-1, LOX-1 and von Willebrand factor (VWF) were conjugated to the surface of lipid-stabilized MBs. Contrast-enhanced ultrasound (CEUS) molecular imaging of the thoracic aorta was performed in wild-type and gene-targeted mice with advanced atherosclerosis (DKO). Histology was performed on carotid endarterectomy samples from patients undergoing surgery for unstable atherosclerosis to assess target expression in humans. In DKO mice, CEUS signal for all four targeted MBs was significantly higher than that for control MBs, and was three to sevenfold higher than in wild-type mice, with the highest signal achieved for VCAM-1 and VWF. All molecular targets were present on the patient plaque surface but expression was greatest for VCAM-1 and VWF. We conclude that ultrasound contrast agents bearing small peptide ligands feasible for human use can be targeted against endothelial cell adhesion molecules for inflammatory cells and platelets for imaging advanced atherosclerotic disease.



http://ift.tt/2GrQ9Ow

HDR Salvage Brachytherapy: Multiple Hypothesis Testing vs Machine Learning Analysis

alertIcon.gif

Publication date: Available online 13 March 2018
Source:International Journal of Radiation Oncology*Biology*Physics
Author(s): Gilmer Valdes, Albert J. Chang, Yannet Interian, Kenton Owen, Shane T. Jensen, Lyle H. Ungar, Adam Cunnan, Timothy D. Solberg, I-Chow Hsu

Teaser

Approximately only 50% of patients benefit from Salvage High Dose Rate Brachytherapy (sHDRB) with the majority of second recurrences occurring distantly. Therefore, a better patient selection before sHDRB is critical. Using Machine learning we found that patients with a Fraction of Positive Cores > 0.35 and a Disease Free Interval < 4.12 years after their initial radiation treatment experienced a higher failure rate after salvage HDRB of 0.75 vs 0.38 for the rest of the population.


http://ift.tt/2tPYmJk

Close margin <2mm is not associated with higher risks of 10-year local recurrence and breast cancer mortality compared to negative margins in women treated with breast-conserving therapy

Publication date: Available online 13 March 2018
Source:International Journal of Radiation Oncology*Biology*Physics
Author(s): Susan Tyler, Pauline T. Truong, Mary Lesperance, Alan Nichol, Chris Baliski, Rebecca Warburton, Scott Tyldesley
PurposeThe 2014 SS0/ASTRO consensus suggests "no ink on tumor" is a sufficient surgical margin for invasive breast cancer treated with breast conserving surgery (BCS). Whether close margin <2 mm is associated with inferior outcomes remains controversial. This study evaluates 10-year outcomes by margin status in a population-based cohort treated with BCS and adjuvant radiotherapy (RT).MethodsSubjects were 10,863 women with pT1-T3, any N, M0 invasive cancer referred from 2001-2011, an era in which the institutional policy was to re-excise close or positive margins, except in select cases. All women underwent BCS and whole breast ± boost RT. Local recurrence (LR) and breast cancer-specific survival (BCSS) were examined using competing risk analysis in cohorts with negative (≥2 mm; n=9241, 85%), close (<2 mm; n=1310, 12%), or positive (tumor touching ink; n=312, 3%) margins. Multivariable analysis (MVA) and matched-pair analysis were performed.ResultsMedian follow-up was 8 years. Systemic therapy was used in 87% of patients. Boost RT was used in 34.1%, 76.9% and 79.5% of patients with negative, close, and positive margins, respectively. In the negative, close, and positive margin cohorts, 10-year cumulative incidence of LR were 1.8%, 2.0%, and 1.1%, (p=0.759). Corresponding BCSS estimates were 93.9%, 91.8%, and 87.9%, (p<0.001). On MVA, close margins were not associated with increased LR (HR 1.25, 95% CI 0.79-1.97, p=0.350) or reduced BCSS (HR 1.25, 95% CI 0.98-1.58, p=0.071) relative to negative margins. On matched-pair analysis, close margin cases had similar LR (p=0.114) and BCSS (p=0.100) compared to negative margin controls.ConclusionSelect cases with close or positive margins in this population-based analysis had similar LR and BCSS compared to negative margins. While these findings do not endorse omitting re-excision for all cases, the data support a policy of accepting carefully selected cases with close margins for adjuvant radiation therapy without re-excision.



http://ift.tt/2FzcLiK

Vascular liver lesions: contemporary views on long-recognized entities



http://ift.tt/2FGMKtE

Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1

Abstract

Purpose

Nasopharyngeal carcinoma (NPC) is one of the most commonly diagnosed cancers worldwide with significantly high prevalence in Southern China. Chemoprevention of cancer with alkylating agent compounds could potentially reverse, suppress, or prevent cancer progression. Cisplatin (CIS) is an antineoplastic or cytotoxic platinum-based drug used for chemotherapy of different types of human cancers such as NPC. Nevertheless, the effects of CIS on the migration and invasion of human NPC cells and the underlying molecular mechanisms have not yet been fully scrutinized.

Methods

In this work, we tested the effect of CIS on the proliferation, migration and invasion of NPC cells. The results exhibited that this drug exerts remarkable inhibitory effects on the proliferation, migration and invasion of NPC cells in a dose-dependent manner. Western blotting and real time RT-PCR were used for expression analyses.

Results

We found that CIS treatment led to a dose-dependent inhibition of Endothelin-1 (ET1) expression, at protein as well as mRNA levels in NPC cells. CIS was also found to activate the expression of BTG1 in NPC cells. Moreover, mechanistic analyses revealed that CIS increased the expression of B cell translocation gene 1 (BTG1) to suppress the expression of ET1. Furthermore, we show that ET1 could not be induced in CIS-resistant cells with suppressed BTG1 expression, and subsequently demote the proliferation, migration and invasion of NPC cells.

Conclusions

These findings provided compelling evidence of the role of CIS in suppressing NPC metastasis and its underlying molecular mechanisms.



http://ift.tt/2pcTRTB

An in vivo evaluation of microbial diversity before and after the photo-activated disinfection in primary endodontic infections: Traditional phenotypic and molecular approaches

elsevier-non-solus.png

Publication date: June 2018
Source:Photodiagnosis and Photodynamic Therapy, Volume 22
Author(s): Maryam Pourhajibagher, Abbas Bahador
BackgroundIt is essential to identify the root canal microbial diversity and count. This is due to the polymicrobial nature of the primary endodontic infection that is associated with the microbial diversity and increased resistance to the antimicrobial agents. Photo-activated disinfection (PAD), also known as antimicrobial photodynamic therapy, is a new promising non-antibiotic approach, studied to prevent microbial resistance and treatment failure.Materials and methodsIn this study, we investigated the effect of PAD on reduction of microbial diversity and count, related with primary endodontic infections. Microbial specimens were collected before PAD from patients infected with the primary endodontic infection. PAD with toluidine blue O (TBO), in combination with diode laser, was performed on infected root canals. Resampling was carried out on the root canal after PAD, and microorganisms were identified by classical microbiological tests using biochemical and analytical profile index (API ® 20A) assays and nucleic acid approaches.ResultsFrom the 36 subjects studied before TBO-PAD, 187 cultivable isolates from 14 different genera and 19 various microbial species were retrieved. Of the bacterial isolates, 45.4% were strict anaerobes including Veillonella parvula, Porphyromonas gingivalis, Propionibacterium acnes, Lactobacillus acidophilus, Campylobacter rectus, and Slackia exigua, in order of their frequency; 45.4% were facultative anaerobes; and 9.2% were microaerophilic bacteria (Aggregatibacter actinomycetemcomitans). This in vivo study revealed significant decrease in the microbial diversity and count of the infected root canal after TBO-PAD (P < 0.05); whereas P. gingivalis strains, the most resistance microorganisms, were recovered in 34% of the samples after TBO-mediated PAD (P > 0.05).ConclusionsTBO-mediated PAD is an effective in exhibiting efficient antimicrobial activity due to the substantial reduction of the microbial diversity and count in the primary endodontic infections.



http://ift.tt/2pa7eVt

Superficial resection combined with photodynamic therapy for successful treatment of facial lupus vulgaris with squamous cell carcinoma

elsevier-non-solus.png

Publication date: June 2018
Source:Photodiagnosis and Photodynamic Therapy, Volume 22
Author(s): Qian Zhang, Xiulian Xu, Rong Zeng, Wenbo Bu, Fang Fang
Skin squamous cell carcinoma is the second most common non-melanoma skin tumor worldwide. Most skin squamous cell carcinoma patients have underlying diseases. Here, we report a 56 year-old patient diagnosed with skin squamous cell carcinoma and with a 30 year course of neglected lupus vulgaris, which was very rare. In this case, we adopted a treatment strategy involving a small wound: superficial resection combined with photodynamic therapy with a satisfied result.



http://ift.tt/2HzhEoj

The response surface methodology speeds up the search for optimal parameters in the photoinactivation of E. coli by photodynamic therapy

Publication date: June 2018
Source:Photodiagnosis and Photodynamic Therapy, Volume 22
Author(s): Larissa S. Amaral, Eduardo B. Azevedo, Janice R. Perussi
Antimicrobial Photodynamic Inactivation (a-PDI) is based on the oxidative destruction of biological molecules by reactive oxygen species generated by the photo-excitation of a photosensitive molecule. When a-PDT is performed with the use of mathematical models, the optimal conditions for maximum inactivation are found. Experimental designs allow a multivariate analysis of the experimental parameters. This is usually made using a univariate approach, which demands a large number of experiments, being time and money consuming. This paper presents the use of the response surface methodology for improving the search for the best conditions to reduce E. coli survival levels by a-PDT using methylene blue (MB) and toluidine blue (TB) as photosensitizers and white light. The goal was achieved by analyzing the effects and interactions of the three main parameters involved in the process: incubation time (IT), photosensitizer concentration (CPS), and light dose (LD). The optimization procedure began with a full 23 factorial design, followed by a central composite one, in which the optimal conditions were estimated. For MB, CPS was the most important parameter followed by LD and IT whereas, for TB, the main parameter was LD followed by CPS and IT. Using the estimated optimal conditions for inactivation, MB was able to inactivate 99.999999% CFU mL−1 of E. coli with IT of 28 min, LD of 31 J cm−2, and CPS of 32 μmol L−1, while TB required 18 min, 39 J cm−2, and 37 μmol L−1. The feasibility of using the response surface methodology with a-PDT was demonstrated, enabling enhanced photoinactivation efficiency and fast results with a minimal number of experiments.

Graphical abstract

image


http://ift.tt/2p8pbUi

Efficacy of Er Cr: YSGG laser therapy at different frequency and power levels on bond integrity of composite to bleached enamel

elsevier-non-solus.png

Publication date: June 2018
Source:Photodiagnosis and Photodynamic Therapy, Volume 22
Author(s): Fahad Alkhudhairy, Mustafa Naseem, Mohammed Bin-Shuwaish, Fahim Vohra
The aim was to evaluate the influence of Er, Cr: YSGG laser therapy at different pulse frequency and power levels on the bond strength and microleakage of bleached enamel. One hundred samples were bleached using in-office whitening agent. Bleached samples were divided into six subgroups, four subgroups was based on laser application parameters (pulse frequency 50 and 30 Hz; Power 4.5 & 6 W) one subgroup was treated with bleach (B) and the other was control (no bleaching, no laser application). All specimens including control were etched with 37% phosphoric acid and composite build-ups were performed. Ten specimens from all the groups (B: Bleach only, L1: 50 Hz–4.5 W, L2: 50 Hz–6 W, L3: 30 Hz–4.5 W, L4:50 Hz–6W & C: Control) were assessed for shear bond strength and microleakage scores. Ten samples from all groups were immersed in 2% methylene blue for 24 h and assessed under a digital microscope for microleakage. The lowest mean bond strength was achieved in bleached group (9.49 ± 0.95) and maximum bond strength was observed in control group (33.97 ± 0.86). The highest mean microleakage score was found in bleached specimens (group B) (630.32 ± 156.58) and the lowest in controls (group C) (36.66 ± 27.33). Among assessed laser frequency and power combinations, 4.5 W and 30 Hz frequency showed maximum adhesive bond integrity (high bond strength and low microleakage) for bleached enamel samples.



http://ift.tt/2DpQcao

Photonic technology for the treatments of venous and arterial ulcers: Case report

elsevier-non-solus.png

Publication date: June 2018
Source:Photodiagnosis and Photodynamic Therapy, Volume 22
Author(s): Fernanda Mansano Carbinatto, Antonio Eduardo de Aquino, Vitória Helena Maciel Coelho, Vanderlei S. Bagnato
In this report, we report a case study on a 50-year-old male patient with different chronic wounds, such as venous ulcer and arterial ulcer in both legs. These wounds have persisted for more than 10 years, despite the different treatments applied, including, different dressings, hyperbaric camera, as well as the used of several medicines of oral and topical application. The case is addressed with the aim to evaluate if treatment that uses combined techniques such as low level laser therapy (LLLT), photodynamic therapy and cellulose membrane is able to improve healing and reduction of time of treatment in those types of chronic wounds. The results show the clinical protocol is effective for the healing of arterial and venous ulcers and can be considered as a promising possibility.



http://ift.tt/2p9Kk0v

CME examination



http://ift.tt/2tPVdcu

Prescribing to save patients money: Ethical considerations

In offering treatment options to their patients, physicians should always consider safety and efficacy. However, it is also important for physicians to consider the cost of medications and the out-of-pocket expense to patients, regardless of whether prescribed for cosmetic, "lifestyle," or medical indications. The final cost for which patients are responsible is dependent on several factors, such as the manufacturer's wholesale price, drug formularies, tiers and contractual copays set by insurance companies, and individual pharmacy discounts.

http://ift.tt/2Gp8QC7

I pledge to prescribe ethically

Throughout its existence, the US Food and Drug Administration has had to cope with various unexpected side effects of medications. Some of the most serious and detrimental to society involve irreparable harm to unborn fetuses. The use of thalidomide, and later isotretinoin, led to the implementation of a series of pregnancy prevention programs. The goal of these programs is to prevent fetal exposure to these medications. In 2002 the System to Manage Accutane Related Teratogenicity (SMART) program requiring physician education, informed consent, rigorous pregnancy testing, and restrictive dispensing policies was put in place.

http://ift.tt/2tJrJNJ

March iotaderma (#289)



http://ift.tt/2GoUFgq

Alopecia areata is a medical disease

Alopecia areata (AA) is a common autoimmune disease characterized by nonscarring hair loss that affects all ages, both sexes, and all skin types. Despite significant advances in understanding the pathomechanism of the disease, the autoimmune comorbidities, and how quality of life (QoL) is affected, treatment for AA is still not considered medically necessary by many insurers and even some physicians.

http://ift.tt/2Fz2m6E

Indentured servitude or junior faculty extension of a residency? An ethical evaluation of the 3 + 3 program structure

Despite a growing push by dermatology residencies for program graduates to pursue careers in academic dermatology, the vast majority of dermatology graduates work in private practice.1 In response to this, some programs have taken novel measures to increase the number of their graduates working in academics. Some of these programs involve combined internal medicine-dermatology residencies and extended research tracks and have been lauded for their ingenuity; others like the 3 + 3 program highlighted in this case scenario have caused concern amongst members of the dermatology community.

http://ift.tt/2DpHh8O

Iotaderma #290



http://ift.tt/2GrLzji

Recommendations for improving the patient experience in specialty encounters

The relationship between patient experience and health care quality has generated significant interest in the patient experience measure. However, it is challenging to find information on how to improve one's patient experience score because scientific data on this topic are weak or lacking, and suggestions provided by scoring vendors are often overgeneralized and not specialty-specific. This review will focus on the current state of evidence supporting factors influencing patient experience (both positive and negative) in outpatient specialist encounters that are applicable to general and surgical dermatology.

http://ift.tt/2DpHkS2

Editorial Board



http://ift.tt/2FAdKiK

CME examination



http://ift.tt/2DqOjdg

Simple solution to prevent postoperative bleeding from paramidline forehead flap

Patients who undergo a forehead flap reconstructive procedure often have postoperative bleeding from the flap's pedicle that necessitates physician intervention and causes significant patient distress. A safe, effective, low-cost, convenient, and reliable method to reduce this problem would be highly desired by reconstructive surgeons.

http://ift.tt/2FJ7O2E

Journal Based CME Instructions and Information



http://ift.tt/2DpPZnm

Dermatology Calendar



http://ift.tt/2GrL2Ok

Answers to CME examination



http://ift.tt/2Doggmc

JAAD Case Reports Article List



http://ift.tt/2GrKVSU

Correction of “sandwiching phenomenon” following horizontal mattress suture

Closure of surgical and traumatic defects under high amounts of tension often involves use of horizontal mattress sutures. When a horizontal mattress suture is performed, a "sandwiching phenomenon," in which the epidermal edges fail to meet, is often observed (Fig 1). It is often found in situations in which a large bite size is used to close a wound under tension; it results from unbalanced tension in the closure, in which the entire load of the closure is in the reticular dermis (Fig 2, A). This results in apposition of the deep tissues, but not of the papillary dermis or epidermis (Fig 2, B), which in turn results in a wound edge profile with exposed dermal edges "sandwiched" by epidermal edges.

http://ift.tt/2FIqyzl

Billing of botulinum toxin for hyperhidrosis: Ethical considerations

Severe hyperhidrosis has significant effects on a patient's daily life. Billing of botulinum toxin injections for this condition varies among practices, despite most insurance covering its use in patients who fail first-line therapies. Although many dermatologists bill insurance for qualified patients, others charge according to the fee schedule for cosmetic botulinum toxin injections, even if patients have insurance that covers the service.1

http://ift.tt/2FznbPf

Tissue control of androgen action: The ups and downs of androgen receptor expression

elsevier-non-solus.png

Publication date: 15 April 2018
Source:Molecular and Cellular Endocrinology, Volume 465
Author(s): Irene Hunter, Colin W. Hay, Bianca Esswein, Kate Watt, Iain J. McEwan
The hormone testosterone plays crucial roles during male development and puberty and throughout life, as an anabolic regulator of muscle and bone structure and function. The actions of testosterone are mediated, primarily, through the androgen receptor, a member of the nuclear receptor superfamily. The androgen receptor gene is located on the X-chromosome and receptor levels are tightly controlled both at the level of transcription of the gene and post-translationally at the protein level. Sp1 has emerged as the major driver of expression of the androgen receptor gene, while auto-regulation by androgens is associated with both positive and negative regulation in a possible cell-selective manner. Research into the networks of positive and negative regulators of the androgen receptor gene are vital in order to understand the temporal and spatial control of receptor levels and the consequences for healthy aging and disease. A clear understanding of the multiple transcription factors participating in regulation of the androgen receptor gene will likely aid in the development and application of hormone therapies to boast or curb receptor activity.



http://ift.tt/2FygHjC

Editorial Board

Publication date: 15 April 2018
Source:Molecular and Cellular Endocrinology, Volume 465





http://ift.tt/2FygFIw

The role of androgen receptors in atherosclerosis

elsevier-non-solus.png

Publication date: 15 April 2018
Source:Molecular and Cellular Endocrinology, Volume 465
Author(s): Kaloyan Takov, Junxi Wu, Martin A. Denvir, Lee B. Smith, Patrick W.F. Hadoke
Male disadvantage in cardiovascular health is well recognised. However, the influence of androgens on atherosclerosis, one of the major causes of many life-threatening cardiovascular events, is not well understood. With the dramatic increase in clinical prescription of testosterone in the past decade, concerns about the cardiovascular side-effects of androgen supplementation or androgen deprivation therapy are increasing. Potential atheroprotective effects of testosterone could be secondary to (aromatase-mediated) conversion into oestradiol or, alternatively, to direct activation of androgen receptors (AR). Recent development of animal models with cell-specific AR knockout has indicated a complex role for androgen action in atherosclerosis. Most studies suggest androgens are atheroprotective but the precise role of AR remains unclear. Increased use of AR knockout models should clarify the role of AR in atherogenesis and, thus, lead to exploitation of this pathway as a therapeutic target.



http://ift.tt/2DqPp8R

Role of the androgen receptor in the central nervous system

elsevier-non-solus.png

Publication date: 15 April 2018
Source:Molecular and Cellular Endocrinology, Volume 465
Author(s): Sakina Mhaouty-Kodja
The involvement of gonadal androgens in functions of the central nervous system was suggested for the first time about half a century ago. Since then, the number of functions attributed to androgens has steadily increased, ranging from regulation of the hypothalamic-pituitary-gonadal axis and reproductive behaviors to modulation of cognition, anxiety and other non-reproductive functions. This review focuses on the implication of the neural androgen receptor in these androgen-sensitive functions and behaviors.



http://ift.tt/2Gu7IgV

Development of selective androgen receptor modulators (SARMs)

elsevier-non-solus.png

Publication date: 15 April 2018
Source:Molecular and Cellular Endocrinology, Volume 465
Author(s): Ramesh Narayanan, Christopher C. Coss, James T. Dalton
The Androgen Receptor (AR), a member of the steroid hormone receptor family, plays important roles in the physiology and pathology of diverse tissues. AR ligands, which include circulating testosterone and locally synthesized dihydrotestosterone, bind to and activate the AR to elicit their effects. Ubiquitous expression of the AR, metabolism and cross reactivity with other receptors limit broad therapeutic utilization of steroidal androgens. However, the discovery of selective androgen receptor modulators (SARMs) and other tissue-selective nuclear hormone receptor modulators that activate their cognate receptors in a tissue-selective manner provides an opportunity to promote the beneficial effects of androgens and other hormones in target tissues with greatly reduced unwanted side-effects. In the last two decades, significant resources have been dedicated to the discovery and biological characterization of SARMs in an effort to harness the untapped potential of the AR. SARMs have been proposed as treatments of choice for various diseases, including muscle-wasting, breast cancer, and osteoporosis. This review provides insight into the evolution of SARMs from proof-of-concept agents to the cusp of therapeutic use in less than two decades, while covering contemporary views of their mechanisms of action and therapeutic benefits.



http://ift.tt/2FygBbK

Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer

S01678140.gif

Publication date: Available online 13 March 2018
Source:Radiotherapy and Oncology
Author(s): Ronan L. McDermott, John G. Armstrong, Pierre Thirion, Mary Dunne, Marie Finn, Cormac Small, Mary Byrne, Carmel O'Shea, Lydia O'Sullivan, Aoife Shannon, Emma Kelly, Dayle J. Hacking
TitleCancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer. NCT01176487.Background & purposeTrials of radiation therapy for the palliation of intra-thoracic symptoms from locally advanced non-small cell lung cancer (NSCLC) have concentrated on optimising fractionation and dose schedules. In these trials, the rates of oesophagitis induced by this "palliative" therapy have been unacceptably high. In contrast, this non-randomised, single-arm trial was designed to assess if more technically advanced treatment techniques would result in equivalent symptom relief and reduce the side-effect of symptomatic oesophagitis.Materials & methodsThirty-five evaluable patients with symptomatic locally advanced or metastatic NSCLC were treated using a three-dimensional conformal technique (3-DCRT) and standardised dose regimens of 39 Gy in 13 fractions, 20 Gy in 5 fractions or 17 Gy in 2 fractions. Treatment plans sought to minimise oesophageal dose. Oesophagitis was recorded during treatment, at two weeks, one month and three months following radiation therapy and 3–6 monthly thereafter. Mean dose to the irradiated oesophagus was calculated for all treatment plans.ResultsFive patients (14%) had experienced grade 2 oesophagitis or dysphagia or both during treatment and 2 other patients had these side effects at the 2-week follow-up. At follow-up of one month after therapy, there was no grade two or higher oesophagitis or dysphagia reported. 22 patients were eligible for assessment of late toxicity. Five of these patients reported oesophagitis or dysphagia (one had grade 3 dysphagia, two had grade 2 oesophagitis, one of whom also had grade 2 dysphagia). Quality of Life (QoL) data at baseline and at 1-month follow up were available for 20 patients. At 1-month post radiation therapy, these patients had slightly less trouble taking a short walk, less shortness of breath, did not feel as weak, had better appetite and generally had a better overall quality of life than they did at baseline. They did report being slightly more tired.ConclusionsThis trial is the first of its kind showing that 3-DCRT provides patients with lower rates of oesophageal toxicity whilst yielding acceptable rates of symptom control. (Sponsored by Cancer Trials Ireland (ICORG) Study number 06-34, the Friends of St. Luke's and the St. Luke's Institute of Cancer Research.)



http://ift.tt/2GtFt1O

A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma

S01678140.gif

Publication date: Available online 13 March 2018
Source:Radiotherapy and Oncology
Author(s): Ting-Shi Su, Ren Luo, Ping Liang, Tao Cheng, Ying Zhou, Yong Huang
PurposeTo build and validate multivariate normal tissue complication probability (NTCP) models for radiation-induced hepatic toxicity (RIHT) after stereotactic body radiation therapy (SBRT).MethodsEighty-five patients with hepatocellular carcinoma (HCC) in a phase II clinical trial were enroled. A progression of at least 1 or 2 points in the Child–Pugh (CP) score post-SBRT was classified as RIHT (≥1 or ≥2). NTCP models for RIHT (≥1 or ≥2) were developed using logistic regression. Nomograms for each model were formulated. The cut-off point of each independent dosimetric risk factor was obtained using receiver-operating characteristic (ROC) analysis. We used an independent cohort (101 patients) for model validation.ResultsTwenty (23.5%) and 12 (14.2%) patients experienced RIHT (≥1) and RIHT (≥2), respectively. V15, VS10, and pretreatment CP (pre-CP) were the optimal predictors for RIHT (≥1 and ≥2) modelling. V15 ≤33.1% and VS10 ≥416.2 mL for RIHT (≥1), and V15 ≤21.5% and VS10 ≥621.8 mL for RIHT (≥2), were the cut-off points. Four NTCP models and their nomograms were generated. These models and nomograms showed good prediction performance (area under the curve (AUC), 0.83–0.89). Our NTCP model (RIHT ≥2) based on V15 plus pre-CP performed well (AUC = 0.78) in a validation cohort.ConclusionV15, VS10, and pre-CP are crucial predictors for RIHT (≥1 and ≥2). Our NTCP models and nomograms were conducive to obtain individual constraints for patients with HCC.Registration NumberChiCTR-IIC-16008233.



http://ift.tt/2tMM8Bq

Doing the right thing: Quality in radiotherapy, a European perspective

alertIcon.gif

Publication date: Available online 13 March 2018
Source:Radiotherapy and Oncology
Author(s): A Vaandering, N Jornet, P Scalliet, M Coffey, Y Lievens




http://ift.tt/2GqRaGy

Seasonal variations in cellular expression of neuropeptide Y (NPY) in testis of the catfish, Clarias batrachus and its potential role in regulation of steroidogenesis

S01969781.gif

Publication date: Available online 13 March 2018
Source:Peptides
Author(s): Priyadarshini Singh, Bechan Lal
The present study demonstrates seasonal variation in the cellular expression of neuropeptide Y (NPY), a known orexigenic neuropeptide, in the testis of the catfish, Clarias batrachus and its relation with testicular steroids. In vitro effects of NPY on androgen production and activities of steroidogenic enzymes were also analyzed to reaffirm the relation between NPY and steroids. NPY-immunoprecipitation was observed in Sertoli cells, interstitial cells and germ cells in recrudescing testis. Intensity of NPY-immunoreaction in the interstitial cells increased steadily with initiation of spermatogenesis and reached maximal in fully grown testes, and then decreased suddenly in the spermiating/spent testis. NPY was also expressed considerably in Sertoli cells in recrudescing testis, but disappeared in the fully grown testis. A moderate NPY-immunoreactivity was also seen in spermatogonial cells in recrudescing testis, but intense NPY-immunoprecipitation was detected in advanced germ cells (spermatids/spermatozoa) in fully mature testis. NPY-immunoreation intensity in interstitial cells showed positive correlation with increasing levels of testicular testosterone and 11-ketotestosterone, and with activities of 3β-HSD & 17β-HSD coinciding with advancing testicular activities. NPY treatment of testicular fragments in vitro stimulated the activities of 3β-HSD & 17β-HSD and increased testosterone & 11-ketotestosterone levels. This study for the first time demonstrates the existence of NPY peptide at cellular levels in fish testis, which stimulates androgen production by acting directly at testicular level.



http://ift.tt/2pdhPOV

Icarus, Blood Pressure, and the Dangers of Flying Too Close to the Sun.

Author: Skolnik, Neil MD
Page: 1097-1099


http://ift.tt/2FyIHDQ

Dietary Patterns to Reduce Weight and Optimize Cardiovascular Health: Persuasive Evidence for Promoting Multiple, Healthful Approaches.

Author: Anderson, Cheryl A.M. PhD, MPH, MS
Page: 1114-1116


http://ift.tt/2FERFvm

Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.

Author: Bennaghmouch, Naoual MD *,; de Veer, Anne J.W.M. MD *,; Bode, Kerstin MD; Mahmoodi, Bakhtawar K. MD, PhD, MPH; Dewilde, Willem J.M. MD, PhD; Lip, Gregory Y.H. MD; Brueckmann, Martina MD; Kleine, Eva MSc; ten Berg, Jurrien M. MD, PhD
Page: 1117-1129


http://ift.tt/2FA0gnb

Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.

Author: James, Stefan MD, PhD
Page: 1130-1131


http://ift.tt/2DoUuPj

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).

Author: Schiavon, Carlos Aurelio MD, PhD; Bersch-Ferreira, Angela Cristine CN, PhD; Santucci, Eliana Vieira Pt, BS; Oliveira, Juliana Dantas CN, BS; Torreglosa, Camila Ragne CN, MSc; Bueno, Priscila Torres Psy, MSc; Frayha, Julia Caldas Psy, BS; Santos, Renato Nakagawa Stat, BS; Damiani, Lucas Petri Stat, MSc; Noujaim, Patricia Malvina MD; Halpern, Helio MD, PhD; Monteiro, Frederico L.J. MD; Cohen, Ricardo Vitor MD, PhD; Uchoa, Carlos H. Pt, PhD; de Souza, Marcio Goncalves MD, PhD; Amodeo, Celso MD, PhD; Bortolotto, Luiz MD, PhD; Ikeoka, Dimas MD, PhD; Drager, Luciano F. MD, PhD; Cavalcanti, Alexandre Biasi MD, PhD; Berwanger, Otavio MD, PhD
Page: 1132-1142


http://ift.tt/2GoVW79

Integrative Omics: Harnessing the Proteome to Maximize the Potential of the Genome.

Author: McGarrah, Robert W. MD; Shah, Svati H. MD, MS, MHS
Page: 1173-1175


http://ift.tt/2DoUj6B

Exercise Therapy and Cardiovascular Toxicity in Cancer.

Author: Scott, Jessica M. PhD; Nilsen, Tormod S. PhD; Gupta, Dipti MD, MPH; Jones, Lee W. PhD
Page: 1176-1191


http://ift.tt/2FyIDnA

Alternating Bundle-Branch Block: What Is the Mechanism?.

Author: Saini, Aditya MD; Padala, Santosh K. MD; Koneru, Jayanthi N. MD; Ellenbogen, Kenneth A. MD
Page: 1192-1194


http://ift.tt/2FGLOpa

Widening Racial Differences in Risks for Coronary Heart Disease.

Author: Nadruz, Wilson Jr MD, PhD *,; Claggett, Brian PhD *,; Henglin, Mir BA; Shah, Amil M. MD, MPH; Skali, Hicham MD, MSc; Rosamond, Wayne D. PhD; Folsom, Aaron R. MD, MPH; Solomon, Scott D. MD; Cheng, Susan MD, MMSc, MPH
Page: 1195-1197


http://ift.tt/2FAIjov

Letter by Tsuda Regarding Article, "A Novel [alpha]-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

Author: Tsuda, Kazushi MD
Page: 1198-1199


http://ift.tt/2FEREaM

Letter by Jin-shan and Xue-bin Regarding Article, "A Novel [alpha]-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

Author: Jin-shan, He MD; Xue-bin, Li MD
Page: 1200


http://ift.tt/2GplMYO

Response by Aubdool et al to Letters Regarding Article, "A Novel [alpha]-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".

Author: Aubdool, Aisah A. BSc, MRes, PhD; Argunhan, Fulye BSc, MSc; Thakore, Pratish PhD, BSc, MSc; Brain, Susan D. BSc, PhD
Page: 1201-1202


http://ift.tt/2FG0TYm

Letter by Mutlu and Budinger Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification".

Author: Mutlu, Gokhan M. MD; Budinger, G.R. Scott MD
Page: 1203-1204


http://ift.tt/2Grb1p5

Letter by Jordan and Biaggioni Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification".

Author: Jordan, Jens MD; Biaggioni, Italo MD
Page: 1205-1206


http://ift.tt/2FEhrzW

Letter by Li et al Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification".

Author: Li, Tian MD *,,; Jiang, Shuai MD, PhD *,; Yang, Yang MD, PhD
Page: 1207-1208


http://ift.tt/2GraN1d

Response by Li et al to Letters Regarding Article, "Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification".

Author: Li, Huichu MS; Cai, Jing PhD; Kan, Haidong PhD
Page: 1209-1210


http://ift.tt/2Dt76VG

Myeloid derived-suppressor cells: their role in cancer and obesity

S09527915.gif

Publication date: April 2018
Source:Current Opinion in Immunology, Volume 51
Author(s): Suzanne Ostrand-Rosenberg
Myeloid-derived suppressor cells (MDSC) are present in most individuals with cancer where they inhibit adaptive and innate antitumor immunity and are an obstacle to cancer immunotherapies. Chronic inflammation is characteristic of adipose tissue and is a risk factor for the onset and progression of cancer in obese individuals. Because MDSC accumulate in response to inflammation, it has been hypothesized that one of the mechanisms by which obesity promotes malignancy is through the induction of MDSC. This article reviews the data supporting this hypothesis, the role of leptin and fatty acid metabolism in the induction of MDSC, and the surprising finding that although MDSC promote tumor progression, they are protective against some of the metabolic dysfunction associated with obesity.



http://ift.tt/2FTGQc7

Evidence of transcranial direct current stimulation-generated electric fields at subthalamic level in human brain in vivo

alertIcon.gif

Publication date: Available online 13 March 2018
Source:Brain Stimulation
Author(s): Pratik Y. Chhatbar, Steven A. Kautz, Istvan Takacs, Nathan C. Rowland, Gonzalo J. Revuelta, Mark S. George, Marom Bikson, Wuwei Feng
BackgroundTranscranial direct current stimulation (tDCS) is a promising brain modulation technique for several disease conditions. With this technique, some portion of the current penetrates through the scalp to the cortex and modulates cortical excitability, but a recent human cadaver study questions the amount. This insufficient intracerebral penetration of currents may partially explain the inconsistent and mixed results in tDCS studies to date. Experimental validation of a transcranial alternating current stimulation-generated electric field (EF) in vivo has been performed on the cortical (using electrocorticography, ECoG, electrodes), subcortical (using stereo electroencephalography, SEEG, electrodes) and deeper thalamic/subthalamic levels (using DBS electrodes). However, tDCS-generated EF measurements have never been attempted.Objective/Hypothesis: We aimed to demonstrate that tDCS generates biologically relevant EF as deep as the subthalamic level in vivo.MethodsPatients with movement disorders who have implanted deep brain stimulation (DBS) electrodes serve as a natural experimental model for thalamic/subthalamic recordings of tDCS-generated EF. We measured voltage changes from DBS electrodes and body resistance from tDCS electrodes in three subjects while applying direct current to the scalp at 2 mA and 4 mA over two tDCS montages.ResultsVoltage changes at the level of deep nuclei changed proportionally with the level of applied current and varied with different tDCS montages.ConclusionsOur findings suggest that scalp-applied tDCS generates biologically relevant EF. Incorporation of these experimental results may improve finite element analysis (FEA)-based models.



http://ift.tt/2p9wOtP

Psychological Treatment

alertIcon.gif

Publication date: Available online 12 March 2018
Source:Hematology/Oncology Clinics of North America
Author(s): Thomas B. Strouse, Brenda Bursch

Teaser

Psychological approaches to pain management have been demonstrated to be effective for individuals newly diagnosed with cancer, in remission, and/or with progressive or terminal disease. Modalities that have been demonstrated to be most effective are cognitive behavioral approaches that include relaxation skills and/or hypnotherapy.


http://ift.tt/2Gqrn17

Multizentrische Analyse des Nutzerverhaltens von Cochlea-Implantat-Trägern

10-1055-a-0574-2569-1.jpg

Laryngo-Rhino-Otol
DOI: 10.1055/a-0574-2569

Zusammenfassung Neuartige Cochlear-Implant-Sprachprozessoren bieten die Möglichkeit der Speicherung von Nutzungsdaten (Datalogging). Mit Hilfe dieser Informationen kann eine gezieltere individuelle Betreuung von Patienten ermöglicht werden. Allerdings fehlen bisher Normdaten in größerem Umfang zum individuellen Nutzungsverhalten. Material und Methoden Im Rahmen einer retrospektiven Studie wurden die Nutzungsdaten von 2687 Patienten ausgewertet. Alle Patienten waren mit dem Nucleus 6-System der Firma Cochlear Ltd. versorgt. Ergebnisse Die Daten ermöglichen für die Nutzungsdauer bzw. Tragedauern von Cochlear-Implant-Sprachprozessoren einen Normalbereich festzulegen. Ebenso ist die Identifikation von auffälligem Nutzungsverhalten möglich.
[...]

© Georg Thieme Verlag KG Stuttgart · New York

Article in Thieme eJournals:
Table of contents  |  Abstract  |  Full text



http://ift.tt/2FzWpqd

Effects of nasal septum perforation repair on nasal airflow: An analysis using computational fluid dynamics on preoperative and postoperative three-dimensional models

The purpose of this research is to examine the changes in nasal airflow dynamics before and after the nasal perforation repair.

http://ift.tt/2FIwmJn

Clinical features of nasal and sinonasal inverted papilloma associated with malignancy

Nasal and sinonasal inverted papilloma (IP) are rare benign tumors and have the potential to exhibit malignancy in approximately 10% of cases. This study aimed to analyze the clinical features of IP associated with malignancy. Furthermore, we reviewed our therapeutic strategy and the clinical course of malignant IP.

http://ift.tt/2FBFjs4

Cover Image

Thumbnail image of graphical abstract

The cover image, by G. Haymerle et al., is based on the Correspondence The effect of adjuvant radiotherapy on radial forearm free flap volume after soft palate reconstruction in 13 patients, DOI 10.1111/coa.13042.



http://ift.tt/2DqgWYi

Author Guidelines



http://ift.tt/2FyEboS

Issue Information



http://ift.tt/2FEDwOG

Thyroid Disease Around the World

Thyroid disease is one of the most common pathologies in the world, with two of the most clinically important subgroups being iodine deficiency and thyroid goiter, and thyroid cancer. This review looks at the current state of thyroid disease in the world and evaluates the future direction in terms of thyroid disease treatment and prevention. Several of the most impactful epidemiologic studies are presented and analyzed, as well as a brief overview of the current socioeconomic burden of disease.

http://ift.tt/2FTAuJN

Asthma-Related Mortality in the United States of America, 1999-2015: A Multiple Causes of Death Analysis

Asthma mortality based on the underlying cause of death (UCOD) underestimates disease burden.

http://ift.tt/2DqQj5h

Sunscreen sun protection factor (SPF): Is higher better?

The harmful properties of sunlight are well known. Actinic keratoses occur nearly exclusively in chronically sun exposed skin. Nonmelanoma skin cancer, especially squamous cell carcinoma, is strongly linked to sun exposure. The International Agency for Research on Cancer (IARC) of the World Health Organization classifies sunlight as a Group I carcinogen.1 Sun exposure is also strongly associated with photoaging. It is estimated that 80% or more of the changes in the skin that occur over time are due to the extrinsic effects of sunlight.

http://ift.tt/2HucaeQ

Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: results from UNCOVER-1, -2, and -3

The impact of ixekizumab treatment for psoriasis on cardiovascular-related parameters in patients is unknown., Ixekizumab maintenance dosing (12-60-weeks) had a neutral impact on cardiovascular-related parameters (including total cholesterol, LDL-cholesterol, HDL-cholesterol, LDL/HDL, triglycerides), Ixekizumab's neutral impact on cardiovascular-related parameters should not alter decisions to treat with other medications/interventions targeting cardiovascular-related parameters.

http://ift.tt/2p81Xh4

Temporal dynamics of gut microbiota in triclocarban-exposed weaned rats

Abstract

Widely used as an antimicrobial in antibacterial bar soaps, triclocarban (3,4,4′-trichlorocarbanilide; TCC) is effective against Gram-positive bacteria but shows little efficacy against Gram-negative strains, potentially altering the composition of indigenous microflora within and on the human body. To date, the consequence of continuous or previous nonprescription antimicrobial exposure from compounds in personal care products on commensal microflora is still elusive. Previous research has shown that TCC exposure during gestation and lactation induced dysbiosis of gut microbial communities among exposed dams and neonates. However, the impact of antimicrobial exposure specifically after discontinuation of the use of TCC on the gut microbiota has not been investigated. In this study, weaned Sprague Dawley rats (postnatal day, PND 22) were provided ad lib access to TCC-supplemented diet (0.2% w/w or 0.5% w/w) for 4 weeks (phase I) followed by a 4-week washout period (phase II) to determine gut microflora changes both during continuous exposure to TCC and to determine the potential rebound following TCC withdrawal. Fecal samples were collected at baseline (PND 22) prior to TCC exposure and throughout phase I and phase II. The V4 region of 16S rDNA was sequenced from extracted total fecal DNA with the MiSeq platform. Exposure to both 0.2% w/w and 0.5% w/w TCC was sufficient to alter diversity of microbiota during phase I of treatment. This effect was further prolonged into phase II, even when TCC exposure was discontinued. Collectively, these data highlight the impact of both continuous and prior TCC exposure on gut microbial ecology and shed light onto the potential long-term health risk of daily nonprescription antimicrobial personal care product use.



http://ift.tt/2pcUpsJ

Prevalence of C-shaped canal system in mandibular first and second molars in a Saudi population assessed via cone beam computed tomography: a retrospective study

Abstract

Objectives

The purpose of this study was to determine the prevalence of the C-shaped root canal configuration, location of the longitudinal groove, sex differences, and unilateral/bilateral presence in mandibular first and second molars in a Saudi population using cone beam computed tomography (CBCT).

Materials and methods

CBCT images for the mandibular first and second molars of 487 patients (a total of 529 first molars and 681 s molars) were evaluated. The teeth were assessed for the presence of C-shaped root canals according to Fan criteria. Subdivisions were also made according to sex, direction of the longitudinal groove, and unilateral/bilateral presence.

Results

Only one C-shaped mandibular first molar was observed (0.19%), whereas 62 second molars (9.1%) exhibited C-shaped anatomy. Unilateral presence of the C-shaped root canal system was more common (53.85%). Female patients had a higher prevalence than males. Longitudinal grooves were most commonly found on the root lingual surface (58.1%).

Conclusions

The prevalence of the C-shaped canal configuration in a Saudi Arabian population was 0.19% in the mandibular first molar and 9.1% in the mandibular second molar. Longitudinal groove prevalence was highest on the lingual surface. Women had a significantly higher prevalence of the C-shaped canal configuration than men. Patients with unilateral presence of the C-shaped canal configuration were more common than those with bilateral presence.

Clinical relevance

Tooth type, patient sex, and ethnicity can help clinicians predict the prevalence of the C-shaped canal system in mandibular molars.



http://ift.tt/2Hx59tC

Quick synthesis of 2-propanol derived fluorescent carbon dots for bioimaging applications

Publication date: April 2018
Source:Optical Materials, Volume 78
Author(s): Raja Angamuthu, Priya Palanisamy, Vasanthakumar Vasudevan, Sedhu Nagarajan, Ramesh Rajendran, Raj Vairamuthu
Herein, for the first time, we present a one-pot ingenious preparative method for fluorescent carbon dots from 2-propanol (2P-CDs) without external treatments. Structure, morphology, chemical composition and fluorescence properties of the 2P-CDs were examined. These results confirm that the as-synthesized 2P-CDs are amorphous, monodispersed, spherical and the average particle size is 2.5 ± 0.7 nm. Most importantly, excitation-dependent emission properties were observed, which suggest that these 2P-CDs may be used in multicolor bioimaging applications. When incubated with HeLa cells, the 2P-CDs exhibit low cytotoxicity, and positive biocompatibility. Confocal microscopy image shows the uptake of 2P-CDs by HeLa cells and the application of probable biomarker is demonstrated.

Graphical abstract

image


http://ift.tt/2HzcvNo

Impact of database quality in knowledge-based treatment planning for prostate cancer

S18798500.gif

Publication date: Available online 13 March 2018
Source:Practical Radiation Oncology
Author(s): Phillip D.H. Wall, Robert L. Carver, Jonas D. Fontenot
PurposeInvestigate dose-volume prediction improvements in a common knowledge-based planning (KBP) method using a Pareto plan database compared to using a conventional, clinical plan database.MethodsTwo plan databases were created using retrospective, anonymized data of 124 VMAT prostate cancer patients. The clinical plan database (CPD) contained planning data from each patient's clinically-treated VMAT plan, which were manually optimized by various planners. The multi-criteria optimization database (MCOD) contained Pareto-optimal plan data from VMAT plans created using a standardized multi-criteria optimization protocol. Overlap volume histograms, incorporating fractional OAR volumes only within the treatment fields, were computed for each patient and used to match new patient anatomy to similar database patients. For each database patient, CPD and MCOD KBP predictions were generated for D10, D30, D50, D65, and D80 of the bladder and rectum in a leave-one-out manner. Prediction achievability was evaluated through a re-planning study on a subset of 31 randomly selected database patients using the best KBP predictions, regardless of plan database origin, as planning goals.ResultsMCOD predictions were significantly lower than CPD predictions for all five bladder dose-volumes and rectum D50 (p=0.004) and D65 (p<0.001), while CPD predictions for rectum D10 (p=0.005) and D30 (p<0.001) were significantly less than MCOD predictions. KBP predictions were statistically achievable in the re-plans for all predicted dose-volumes, excluding D10 of bladder (p=0.03) and rectum (p=0.04). Compared to clinical plans, re-plans showed significant average reductions in Dmean for bladder (7.8Gy; p<0.001) and rectum (9.4Gy; p<0.001), while maintaining statistically similar PTV, femoral head, and penile bulb dose.ConclusionKBP dose-volume predictions derived from Pareto plans were more optimal overall than those resulting from manually optimized clinical plans, which significantly improved KBP-assisted plan quality.



http://ift.tt/2FOdYlA

Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan

Publication date: Available online 12 March 2018
Source:Acta Biomaterialia
Author(s): Yuanman Yu, Rui Chen, Yi Sun, Yuanzhong Pan, Wei Tang, Shuang Zhang, Lingyan Cao, Yuan Yuan, Jing Wang, Changsheng Liu
Emerging evidence suggests that vascular endothelial growth facto (VEGF) is important in the treatment of various ischemic and cardiovascular diseases. However, it often suffers from high cost and easy deactivation with a short half-life. Here, we describe a synthetic 2-N, 6-O-sulfated chitosan (26SCS) with a high affinity to VEGF promoting the binding of the signaling protein to its VEGF receptor 2 (VEGFR2), activating receptor phosphorylation and pro-angiogenic related genes expression, and further stimulating downstream VEGF-dependent endothelial cell viability, migration, tube formation and rat aortic rings outgrowth. Interestingly, the obvious recruitment of mural cells were occurred to stabilize the sprouted microvessels. In addition, the pro-angiogenic potential of 26SCS composited VEGF was confirmed in vivo using the chick embryo chorioallantoic membrane (CAM) assay with an extensive perfusable vascular network. A longer monitoring was administered subcutaneously to mice in a biocompatible gelatin sponge and showed that VEGF with 26SCS had the capability to efficiently enhance neovascularization. These findings highlight that 26SCS, the semi-synthetic natural polymer, may be a promising coagent with VEGF for vascular therapy.Statement of significanceVascular endothelial growth factor (VEGF) is crucial for facilitating angiogenesis to supply oxygen and nutrient during wound healing and tissue regeneration. However, appropriate use of VEGF is an ongoing challenge due to its rapidly clearance and severe side effects at higher dosage. In this study, we described a synthetic 2-N, 6-O-sulfated chitosan (26SCS) with a high affinity to VEGF, which could significantly promote its binding capacity to VEGF receptor 2 and further stimulate the angiogenic behavior of endothelial cells. We further confirmed that 26SCS was spatially combined with VEGF in a "lying manner", and this spatial arrangement was more conducive to exposure of the receptor binding domain of VEGF. Additionally, it also promoted in vivo angiogenesis in a chicken chorioallantoic membrane assay and mouse subcutaneous implant model. This strategy may afford a new avenue to enhance pro-angiogenic capacity of VEGF.

Graphical abstract

image


http://ift.tt/2FA39nI

Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy

Publication date: Available online 13 March 2018
Source:Acta Biomaterialia
Author(s): Zhiqi Xie, Wangwei Guo, Ningning Guo, Mingyi Huangfu, Huina Liu, Mengting Lin, WenHong Xu, Jiejian Chen, TianTian Wang, Qichun Wei, Min Han, Jianqing Gao
Although existing nanomedicines have focused on the tumor microenvironment with the goal of improving the effectiveness of conventional chemotherapy, the penetration of a tumor's core still represents a formidable barrier for existing drug delivery systems. Therefore, a novel multifunctional hypoxia-induced size-shrinkable nanoparticle has been designed to increase the penetration of drugs, nucleic acids, or probes into tumors. This cooperative strategy relies on three aspects: (i) the responsiveness of nanoparticles to hypoxia, which shrink when triggered by low oxygen concentrations; (ii) the core of a nanoparticle involves an internal cavity and strong positive charges on the surface to deliver both doxorubicin and siRNA; and (iii) a reactive oxygen species (ROS) probe is incorporated in the nanoparticle to monitor its preliminary therapeutic response in real time, which is expected to realize the enhanced efficacy together with the ability to self-monitor the anticancer activity. A more effective inhibition of tumor growth was observed in tumor-bearing zebrafish, demonstrating the feasibility of this cooperative strategy for in vivo applications. This research highlights a promising value in delivering drugs, nucleic acids, or probes to a tumor's core for cancer imaging and treatment.Statement of significanceHypoxia-induced chemoresistance of tumor cells still represents a formidable barrier, as it is difficult for existing drug delivery systems to penetrate the tumor hypoxia core. This study involves the hypoxia-responsive size-shrinkable nanoparticle co-delivery of DOX and siRNA to enhance the penetration of DOX deep within tumors and subsequently disturb crucial pathways of cancer development induced by hypoxia and to improve sensitization to DOX chemotherapy. Furthermore, the nanopreparation can combine the ROS probe as a self-reporting nanopreparation to realize the function of real-time feedback efficacy, which has a good application prospect in the diagnosis and treatment of cancer.

Graphical abstract

image


http://ift.tt/2tSrO1J

Unilateral Cleft Lip Rhinoplasty

alertIcon.gif

Publication date: Available online 13 March 2018
Source:Operative Techniques in Otolaryngology-Head and Neck Surgery
Author(s): Phillip Montague, Mark Armeni
Cleft lip rhinoplasty is a challenging procedure both in terms of obtaining desirable appearance and function, but also in achieving consistency across one's patient population. Classically, formal nasal surgery was delayed until the patient had completed nasal and mid-facial growth, however, this paradigm is changing, and more rhinoplasty is being performed at the time of the lip repair which has revolutionized patient outcomes. The three options for repair in terms of timing are designated as primary, intermediate, and secondary (defined later in this text). At our institution, the majority of cases are either primary or secondary, with intermediate rhinoplasty reserved for only special circumstances. This article aims to describe the relevant anatomy and its aberrancy as well as discuss the surgical techniques to repair the cleft nasal deformity.



http://ift.tt/2p9q2Ey

Histone Deacetylases 1 and 2 Regulate Microglia Function during Development, Homeostasis, and Neurodegeneration in a Context-Dependent Manner

Publication date: Available online 13 March 2018
Source:Immunity
Author(s): Moumita Datta, Ori Staszewski, Elena Raschi, Maximilian Frosch, Nora Hagemeyer, Tuan Leng Tay, Thomas Blank, Mario Kreutzfeldt, Doron Merkler, Stephanie Ziegler-Waldkirch, Patrick Matthias, Melanie Meyer-Luehmann, Marco Prinz
Microglia as tissue macrophages contribute to the defense and maintenance of central nervous system (CNS) homeostasis. Little is known about the epigenetic signals controlling microglia function in vivo. We employed constitutive and inducible mutagenesis in microglia to delete two class I histone deacetylases, Hdac1 and Hdac2. Prenatal ablation of Hdac1 and Hdac2 impaired microglial development. Mechanistically, the promoters of pro-apoptotic and cell cycle genes were hyperacetylated in absence of Hdac1 and Hdac2, leading to increased apoptosis and reduced survival. In contrast, Hdac1 and Hdac2 were not required for adult microglia survival during homeostasis. In a mouse model of Alzheimer's disease, deletion of Hdac1 and Hdac2 in microglia, but not in neuroectodermal cells, resulted in a decrease in amyloid load and improved cognitive impairment by enhancing microglial amyloid phagocytosis. Collectively, we report a role for epigenetic factors that differentially affect microglia development, homeostasis, and disease that could potentially be utilized therapeutically.

Graphical abstract

image

Teaser

Little is known about the epigenetic signals that control microglia function in vivo. Datta et al. show that histone deacetylases Hdac1 and Hdac2 are essential for microglial survival and expansion during development but not during steady state. In Alzheimer's disease mouse model, deletion of microglial Hdac1 and Hdac2 reduces amyloid pathology and improves cognitive function.


http://ift.tt/2FQScO4

Biomaterial scaffolds for non-invasive focal hyperthermia as a potential tool to ablate metastatic cancer cells

Publication date: June 2018
Source:Biomaterials, Volume 166
Author(s): Francisco Pelaez, Navid Manuchehrabadi, Priyatanu Roy, Harishankar Natesan, Yiru Wang, Emilian Racila, Heather Fong, Kevin Zeng, Abby M. Silbaugh, John C. Bischof, Samira M. Azarin
Currently, there are very few therapeutic options for treatment of metastatic disease, as it often remains undetected until the burden of disease is too high. Microporous poly(ε-caprolactone) biomaterials have been shown to attract metastasizing breast cancer cells in vivo early in tumor progression. In order to enhance the therapeutic potential of these scaffolds, they were modified such that infiltrating cells could be eliminated with non-invasive focal hyperthermia. Metal disks were incorporated into poly(ε-caprolactone) scaffolds to generate heat through electromagnetic induction by an oscillating magnetic field within a radiofrequency coil. Heat generation was modulated by varying the size of the metal disk, the strength of the magnetic field (at a fixed frequency), or the type of metal. When implanted subcutaneously in mice, the modified scaffolds were biocompatible and became properly integrated with the host tissue. Optimal parameters for in vivo heating were identified through a combination of computational modeling and ex vivo characterization to both predict and verify heat transfer dynamics and cell death kinetics during inductive heating. In vivo inductive heating of implanted, tissue-laden composite scaffolds led to tissue necrosis as seen by histological analysis. The ability to thermally ablate captured cells non-invasively using biomaterial scaffolds has the potential to extend the application of focal thermal therapies to disseminated cancers.

Graphical abstract

image


http://ift.tt/2txIP0G

Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery

Publication date: June 2018
Source:Biomaterials, Volume 166
Author(s): Wei-Lun Tang, Wei-Hsin Tang, Andras Szeitz, Jayesh Kulkarni, Pieter Cullis, Shyh-Dar Li
The solvent-assisted active loading technology (SALT) was developed for encapsulating a water insoluble weak base into the liposomal core in the presence of 5% DMSO. In this study, we further examined the effect of various water miscible solvents in promoting active loading of other types of drugs into liposomes. To achieve complete drug loading, the amount of solvent required must result in complete drug solubilization and membrane permeability enhancement, but must be below the threshold that induces liposomal aggregation or causes bilayer disruption. We then used the SALT to load gambogic acid (GA, an insoluble model drug that shows promising anticancer effect) into liposomes, and optimized the loading gradient and lipid composition to prepare a stable formulation (Lipo-GA) that displayed >95% drug retention after incubation with serum for 3 days. Lipo-GA contained a high drug-to-lipid ratio of 1/5 (w/w) with a mean particle size of ∼75 nm. It also displayed a prolonged circulation half-life (1.5 h vs. 18.6 h) and enhanced antitumor activity in two syngeneic mice models compared to free GA. Particularly, complete tumor regression was observed in the EMT6 tumor model for 14 d with significant inhibition of multiple oncogenes including HIF-1α, VEGF-A, STAT3, BCL-2, and NF-κB.

Graphical abstract

image


http://ift.tt/2twhAno

“Stepwise Extraction” strategy-based injectable bioresponsive composite implant for cancer theranostics

Publication date: June 2018
Source:Biomaterials, Volume 166
Author(s): Bowen Yang, Han Lin, Chen Dai, Yu Chen, Jianlin Shi
"Smart" bioresponsive materials, which are sensitive to biological signals or pathological abnormalities, are appealing therapeutic platforms for the development of next-generation cancer theranostics. In this work, a novel "stepwise extraction" strategy has been proposed and demonstrated in constructing injectable bioresponsive composite implant, which features unique theranostic responsivenesses to exogenous and external triggers. The as-designed implant exhibits theranostic functions and biodegradability for cancer treatment based on the change of intratumoral microenvironment and the needs of therapeutic process. This "stepwise extraction" process, that is, "solvent extraction", "manganese extraction" and "phosphorus extraction", significantly promoted the biodegradation and disintegration of the bioresponsive implant step by step, accompanied by the corresponding component releases from the PLGA framework and furthermore, accomplished different specific theranostic functions needed at different treatment stages. This is the first demonstration of bioresponsive organic-inorganic hybrid implant with marked theranostic functions and excellent biodegradability by a "stepwise extraction" approach, paving the way to the solutions of unsatisfactory therapeutic efficacy and strong side effects in current cancer therapeutic modalities.

Graphical abstract

image


http://ift.tt/2FGD2uE

Cargo-free particles of ammonio methacrylate copolymers: From pharmaceutical inactive ingredients to effective anticancer immunotherapeutics

Publication date: June 2018
Source:Biomaterials, Volume 166
Author(s): Maryam Alsadat Shetab Boushehri, Valentin Stein, Alf Lamprecht
Nanoparticles create exciting platforms for anticancer immunotherapy and vaccination, though their inherent immunomodulatory properties have remained underexploited. Ammonio methacrylate copolymers (AMC) are well-established excipients in pharmaceutical industry and components of controlled-release oral formulations. Here, we demonstrate that nanoscaling of type A and B AMC (Eudragit® RL and RS) endows these inactive ingredients immunostimulatory properties exploitable for cancer therapy. The particles induce the secretion of various pro-inflammatory cytokines and chemokines from the cells of innate immunity. Though the underlying mechanisms are not fully uncovered, the current work established the partial involvement of Toll-like Receptor 4 (TLR4) and Nuclear factor κB (NF-κB). The size and charge-dependency of the particles' pro-inflammatory properties and cytokine/chemokine induction profile was also demonstrated. Within the context of cancer immunotherapy, biweekly peritumoral nanoparticle injection led to a complete regression of the syngeneic colorectal tumor, or a significant growth retardation thereof, considerably extending the survival of tumor-bearing animals. Additionally, presence of the immunological memory in treated animals was established. Given their better economical and relatively safer profile compared to well-established chemo- and immunotheraputics, and their ability to serve as carriers for drug targeting, vaccination and combination therapy, AMC nanoparticles (AMCNP) are fascinating subjects for further research in the field of cancer therapy.

Graphical abstract

image


http://ift.tt/2oY0GZZ

Harnessing biochemical and structural cues for tenogenic differentiation of adipose derived stem cells (ADSCs) and development of an in vitro tissue interface mimicking tendon-bone insertion graft

elsevier-non-solus.png

Publication date: May 2018
Source:Biomaterials, Volume 165
Author(s): Sajeesh Kumar Madhurakkat Perikamana, Jinkyu Lee, Taufiq Ahmad, Eun Mi Kim, Hayeon Byun, Sangmin Lee, Heungsoo Shin
Tendon-bone interface tissue is extremely challenging to engineer because it exhibits complex gradients of structure, composition, biologics, and cellular phenotypes. As a step toward engineering these transitional zones, we initially analyzed how different (topographical or biological) cues affect tenogenic differentiation of adipose-derived stem cells (ADSCs). We immobilized platelet-derived growth factor - BB (PDGF-BB) using polydopamine (PD) chemistry on random and aligned nanofibers and investigated ADSC proliferation and tenogenic differentiation. Immobilized PDGF greatly enhanced the proliferation and tenogenic differentiation of ADSCs; however, nanofiber alignment had no effect. Interestingly, the PDGF immobilized aligned nanofiber group showed a synergistic effect with maximum expression of tenogenic markers for 14 days. We also generated a nanofiber surface with spatially controlled presentation of immobilized PDGF on an aligned architecture, mimicking native tendon tissue. A gradient of immobilized PDGF was able to control the phenotypic differentiation of ADSCs into tenocytes in a spatially controlled manner, as confirmed by analysis of the expression of tenogenic markers and immunofluorescence staining. We further explored the gradient formation strategy by generation of a symmetrical gradient on the nanofiber surface for the generation of a structure mimicking bone-patellar-tendon-bone with provision for gradient immobilization of PDGF and controlled mineralization. Our study reveals that, together with biochemical cues, favorable topographical cues are important for tenogenic differentiation of ADSCs, and gradient presentation of PDGF can be used as a tool for engineering stem cell–based bone-tendon interface tissues.



http://ift.tt/2oUp2Dm

Hydrotalcite monolayer toward high performance synergistic dual-modal imaging and cancer therapy

elsevier-non-solus.png

Publication date: May 2018
Source:Biomaterials, Volume 165
Author(s): Xuan Mei, Wei Wang, Liang Yan, Tingting Hu, Ruizheng Liang, Dan Yan, Min Wei, David G. Evans, Xue Duan
Recently, theranostic has drawn tremendous attention by virtue of the nanotechnology development and new material exploration. Herein, we reported a novel theranostic system by loading Au nanoclusters (AuNCs) and Chlorin e6 (photosensitizer, Ce6) onto the monolayer nanosheet surface of Gd-doped layered double hydroxide (Gd-LDH). The as-prepared Ce6&AuNCs/Gd-LDH exhibits a largely enhanced fluorescence quantum yield (QY) of 18.5% relative to pristine AuNCs (QY = 3.1%) as well as superior T1 magnetic resonance imaging (MRI) performance (r1 = 17.57 mM−1s−1) compared with commercial MRI contrast agent (Gd(III)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Gd-DOTA): r1 ≈ 3.4 mM−1s−1), resulting from a synergistic effect between AuNCs and Gd-LDH. In addition, both in vitro and in vivo therapeutic evaluations demonstrate an efficient dual-modality imaging guided anticancer performance, especially the synergetic enhanced magnetic resonance/fluorescence (MR/FL) visualization of tumor site. Therefore, this work demonstrates a successful paradigm for the design and preparation of LDHs monolayer-based theranostic material, which holds great promises in practical applications.



http://ift.tt/2Iddunf

Editorial Board

alertIcon.gif

Publication date: May 2018
Source:Biomaterials, Volume 164





http://ift.tt/2I5fjTc

In vivo spatiotemporal dynamics of NG2 glia activity caused by neural electrode implantation

elsevier-non-solus.png

Publication date: May 2018
Source:Biomaterials, Volume 164
Author(s): Steven M. Wellman, Takashi D.Y. Kozai
Neural interface technology provides direct sampling and analysis of electrical and chemical events in the brain in order to better understand neuronal function and treat neurodegenerative disease. However, intracortical electrodes experience inflammatory reactions that reduce long-term stability and functionality and are understood to be facilitated by activated microglia and astrocytes. Emerging studies have identified another cell type that participates in the formation of a high-impedance glial scar following brain injury; the oligodendrocyte precursor cell (OPC). These cells maintain functional synapses with neurons and are a crucial source of neurotrophic support. Following injury, OPCs migrate toward areas of tissue injury over the course of days, similar to activated microglia. The delayed time course implicates these OPCs as key components in the formation of the outer layers of the glial scar around the implant. In vivo two-photon laser scanning microscopy (TPLSM) was employed to observe fluorescently-labeled OPC and microglia reactivity up to 72 h following probe insertion. OPCs initiated extension of cellular processes (2.5 ± 0.4 μm h−1) and cell body migration (1.6 ± 0.3 μm h−1) toward the probe beginning 12 h after insertion. By 72 h, OPCs became activated at a radius of about 190.3 μm away from the probe surface. This study characterized the early spatiotemporal dynamics of OPCs involved in the inflammatory response induced by microelectrode insertion. OPCs are key mediators of tissue health and are understood to have multiple fate potentials. Detailed spatiotemporal characterization of glial behavior under pathological conditions may allow identification of alternative intervention targets for mitigating the formation of a glial scar and subsequent neurodegeneration that debilitates chronic neural interfaces.



http://ift.tt/2oUpG3D

A synthetic stroma-free germinal center niche for efficient generation of humoral immunity ex vivo

elsevier-non-solus.png

Publication date: May 2018
Source:Biomaterials, Volume 164
Author(s): Kyung-Ho Roh, Hannah W. Song, Pallab Pradhan, Kevin Bai, Caitlin D. Bohannon, Gordon Dale, Jardin Leleux, Joshy Jacob, Krishnendu Roy
B cells play a major role in the adaptive immune response by producing antigen-specific antibodies against pathogens and imparting immunological memory. Following infection or vaccination, antibody-secreting B cells and memory B cells are generated in specialized regions of lymph nodes and spleens, called germinal centers. Here, we report a fully synthetic ex-vivo system that recapitulates the generation of antigen-specific germinal-center (GC) like B cells using material-surface driven polyvalent signaling. This synthetic germinal center (sGC) reaction was effectively induced using biomaterial-based artificial "follicular T helper cells (TFH)" that provided both natural CD40-CD40L ligation as well as crosslinking of CD40 and by mimicking artificial "follicular dendritic cells (FDC)" to provide efficient, polyvalent antigen presentation. The artificial sGC reaction resulted in efficient B cell expansion, immunoglobulin (Ig) class switching, and expression of germinal center phenotypes. Antigen presentation during sGC reaction selectively enhanced the antigen-specific B cell population and induced somatic hyper-mutations for potential affinity maturation. The resulting B cell population consisted primarily of GC-like B cells (centrocytes) as well as some plasma-like B cells expressing CD138. With concurrent cell sorting, we successfully created highly enriched populations of antigen-specific B cells. Adoptive transfer of these GC-like B cells into non-irradiated isogeneic or non-lethally irradiated congenic recipient mice showed successful engraftment and survival of the donor cells for the 4 week test period. We show that this material-surface driven sGC reaction can be successfully applied to not only splenic B cells but also B cells isolated from more therapeutically relevant sources such as peripheral blood mononuclear cells (PBMCs), thus making our current work an exciting prospect in the new era of personalized medicine and custom-immunotherapy.



http://ift.tt/2oYAQEG

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy

elsevier-non-solus.png

Publication date: May 2018
Source:Biomaterials, Volume 164
Author(s): Hyunjoon Kim, Lin Niu, Peter Larson, Tamara A. Kucaba, Katherine A. Murphy, Britnie R. James, David M. Ferguson, Thomas S. Griffith, Jayanth Panyam
Cytotoxic T lymphocytes (CTLs) play a major role in cancer immunotherapy because of their ability to directly kill tumor cells and secrete tumor suppressive cytokines. Anticancer vaccines aim to provoke tumor-specific CTL responses, which require activation of antigen presenting cells (APCs) including dendritic cells (DCs) and macrophages. Therefore, a potent immunostimulatory adjuvant capable of activating APCs is an essential component of anticancer vaccines. In this study, we introduce novel TLR 7/8 bi-specific agonists that significantly enhance cytokine secretion compared to TLR7 mono-selective compounds. Encapsulation of these TLR 7/8 agonists in poly(lactide-co-glycolide) (PLGA) nanoparticles increased the co-stimulatory molecule expression and antigen presentation via MHC I by DCs compared to the soluble agonist. When administered subcutaneously, these nanoparticles migrated to draining lymph node and triggered DC activation and expansion. This lead to expansion of antigen-specific CD8 T cells and enhanced CTL response, which resulted in significant prophylactic and therapeutic efficacy in melanoma, bladder and renal cell carcinoma tumor models. Importantly, our studies demonstrate significant reductions in systemic metastasis with the nanoparticle vaccine. Our results suggest novel TLR 7/8 agonist-encapsulated nanoparticles are potent immunostimulatory adjuvants for cancer immunotherapy.



http://ift.tt/2oTxXVB

Longitudinally extensive transverse myelitis following dengue virus infection: A rare entity

pae.gif

Sunil Malik, Sonal Saran, Archana Dubey, Ajay Punj

Annals of African Medicine 2018 17(2):86-89

Association of dengue fever with longitudinally extensive transverse myelitis in pediatric age group is a rare entity. We describe a case of 15 year old adolescent male who presented with dengue fever and in whom symptoms of transverse myelitis developed 4 weeks after fever (post-infectious stage). Magnetic resonance imaging confirmed the diagnosis of longitudinally extensive transverse myelitis involving dorso-lumbar cord. Patient recovered almost completely with minimal residual neurological deficit after a six weeks course of corticosteroids and supportive management including physiotherapy.

http://ift.tt/2FIoveA

Coexisting cerebral venous sinus thrombosis and posterior reversible encephalopathy syndrome in a preeclamptic female

pae.gif

Sonal Saran, Pradeep Bansal, Saurabh Singhal, Ankita Malik

Annals of African Medicine 2018 17(2):94-95



http://ift.tt/2FPRMrb

Electroencephalography abnormalities in generalized epilepsy and their predictors: A multicenter experience

pae.gif

Lukman Femi Owolabi, Shehu Sale, Shakirah Desola Owolabi, Aisha Nalado, Muhammad Umar, Aminu Abdullahi Taura

Annals of African Medicine 2018 17(2):64-69

Background: In spite of the overwhelming significance of knowledge of basic elements of electroencephalography (EEG) in its application to the diagnostic workup and the management of patients with suspected or already established generalized epilepsy (GE), there is a dearth of data on the pattern and utility of clinical variables that can independently determine EEG abnormalities in GE. Objective: The study was designed to evaluate the frequency and pattern of EEG abnormality as well as assess the utility of clinical variables in predicting the likelihood of an abnormal EEG in GE. Methods: It was a cross-sectional study involving the analysis of EEGs of consecutive patients with clinical diagnosis of idiopathic GE from three centers over a 7-year period. Information on sociodemographic and seizure variables was obtained. The International Federation of Societies for Electroencephalography and Clinical Neurophysiology definition of interictal epileptiform discharges (interictal epileptiform activity [IEA]) was adopted in the study. Results: A total of 403 patients comprising 242 (60%) males and 161 (40%) females with clinical diagnosis of GE had EEG. Their age ranged between 2 weeks and 70 years, with a median age of 21 years and an interquartile age of 26 years. Two hundred and thirty-seven (58.8%) and 213 (52.9%) patients had abnormal EEG and IEA, respectively. Before adjustment for confounders, female gender (P = 0.0001), pediatric age group (P = 0.0388), duration of epilepsy of 1–4 years (P = 0.01387), uncontrolled seizure (P = 0.0060), and seizure frequency (P = 0.0001) were significantly associated with the presence of abnormal EEG. However, age, female gender, poor seizure control, and seizure frequencies were the independent predictors of EEG abnormality. Conclusion: The study showed that about 58% of patients with GE patients had abnormal EEG. Age, poor seizure control, and high frequency of seizure were independent predictors of the presence of EEG abnormality.

http://ift.tt/2HwJ8Lu

Concurrent giant tumoral pseudoangiomatous stromal hyperplasia necessitating bilateral mastectomy

pae.gif

Modupeola Omotara Samaila, Halima Oziohu Aliyu, Lazarus Mungu Yusufu, Shehu Abdullahi

Annals of African Medicine 2018 17(2):82-85

Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign mesenchymal tumor of the breast. Majority occur as diffuse lesions, and diagnosis is often incidental or in a background of other breast pathologies. Bilaterality with multiple tumoral masses in giant breasts is a rarity. We report a 34-year-old nonlactating female with 2-year history of rapid progressive painless bilateral enlargement of the breasts following surgical excision of ill-defined breast lumps which were not subjected to histopathological evaluation a year earlier. Examination revealed bilateral nontender giant breasts extending to the umbilical area with masses which were not attached to overlying skin, Grade 2 pressure ulcers on the lateral posterior breast aspects bilaterally and peau d'orange. There were no other palpable masses or lymph nodes. A clinical assessment of bilateral gigantomastia was made. Bilateral mastectomy revealed giant PASH which was confirmed with positive immunohistochemical reactivity for CD34 and vimentin. No other breast pathologies were seen with extensive sectioning. Diffuse multiple breast lesions with incomplete excision are associated with rapid growth in PASH as seen in this case. The presence of concurrent bilateral giant tumoral masses without any underlying breast pathology is a novelty. The mainstay of treatment in this case is mastectomy despite its benign nature.

http://ift.tt/2FQQL28

Relation between globus pharyngeus and OSA in patients examined simultaneously by PSG and pH monitor: A cross sectional study

Publication date: Available online 12 March 2018
Source:Auris Nasus Larynx
Author(s): Ayako Fukui, Meiho Nakayama, Naoko Sakamoto, Sachie Arima, Shintaro Sato, Motohiko Suzuki, Shingo Murakami
ObjectiveThis was a first cross-sectional single-center study to research the relation between globus pharyngeus, OSA and GERD. Since previous clinical studies have demonstrated a relationship between globus phayrngeus and GERD, however, no reported study on the relation between globus pharyngeus, sleep disorders including OSA, and GERD.MethodsSeventeen patients underwent general and otorhinolaryngological examinations and responded to several questionnaires (ESS, PSQI, HADS, and Globus pharyngeus VAS score) at their first visit, and underwent a gastroesophageal test for 24-h pH monitoring and in-laboratory PSG one to two months later.ResultsNo significant differences were seen in ESS, PSQI, or HADS scores between the groups. The acid exposure time was not significantly different among the groups. The percentage of esophageal reflux time was higher than the percentage of laryngopharyngeal reflux time through the total time as well as the supine period. This indicated that GERD occurred more frequently than laryngopharyngeal reflux. The entire results showed concurrent OSA in 10 cases (59%) and concurrent GERD in 7 cases (41%). The cases with OSA were treated by CPAP or oral appliance, and those treatments were effective for globus pharyngeus.ConclusionAlthough the relation between OSA and globus phayngeus is still controversial, these findings suggest that OSA may be a previously undetected cause of globus pharyngeus. By improving OSA, it may offer an additional option of treatment for those globus pharyngeus cases combined with OSA.



http://ift.tt/2DoC9Sn

Adsorption/desorption of arsenite and arsenate on chitosan and nanochitosan

Abstract

Equilibrium sorption studies of anionic species of arsenite, As(III) ions and arsenate As(V) ions onto two biosorbents, namely, chitosan and nanochitosan, have been investigated and compared. The results and trends in the sorption behavior are novel, and we have observed during the sorption process of the As(III) and As(V) on chitosan, a slow process of desorption occurred after an initial maximum adsorption capacity was achieved, before reaching a final but lower equilibrium adsorption capacity. The same desorption trend, however, is not observed on nanochitosan. The gradual desorption of As(III) and As(V) in the equilibrium sorption on chitosan is attributed to the different fractions of the dissociated forms of arsenic on the adsorbent surface and in solution and the extent of protonation of chitosan with the changing of solution pH during sorption. The change of solution pH during the sorption of arsenite ions on chitosan was also influenced by the interaction between the buffering effect of the arsenite species in the aqueous medium and the physical properties of chitosan. The final equilibrium adsorption capacity of chitosan for As(III) and As(V) was found to be around 500 and 8000 μg/g, respectively, whereas the capacities on nanochitosan are 6100 and 13,000 μg/g, respectively.



http://ift.tt/2tKUNo2

Priming integrin alpha 5 promotes the osteogenic differentiation of human periodontal ligament stem cells due to cytoskeleton and cell cycle changes

Publication date: Available online 13 March 2018
Source:Journal of Proteomics
Author(s): He Wang, Jianjia Li, Xiaoyi Zhang, Tingting Ning, Dandan Ma, Yihong Ge, Shuaimei Xu, Yilin Hao, Buling Wu
To seek a potential target for periodontal tissue regeneration, this study aimed to explore the role of Integrin alpha 5 (ITGA5) in human periodontal ligament stem cells (PDLSCs). Transwell assay, Cell Counting Kit 8 (CCK8) assay, cell cycle assay, alkaline phosphatase (ALP) activity, alizarin red staining, and western blot were used to investigate the effects of ITGA5 on PDLSC migration, proliferation and osteogenic differentiation. The in vivo effect was investigated by nude mice subcutaneous transplantation with cell and hydroxyapatite/β-tricalcium phosphate (HA/β-TCP) complex. The involved mechanism was explored by the iTRAQ proteomic technique and validated by western blot and immunofluorescence. We found that ITGA5forced expression enhanced the proliferation, migration, and osteogenic capacity of PDLSCs, while inhibited ITGA5 expression had the opposite effects. The phosphorylation of focal adhesion kinase (FAK), phosphatidylinositide 3-kinases/protein kinase B (PI3K/AKT), and mitogen-activated protein kinase kinase/extracellular signal-regulated protein kinases 1 and 2 (MEK1/2/ERK1/2) were crucial in this process. Forced expression of ITGA5 in PDLSCs increased osteoid and PDL-like tissue formation in vivo. Proteomic and bioinformatic analysis revealed that cytoskeleton and cell cycle changes were involved. Keratin, type II cytoskeletal 6B (KRT6B) and desmin (DES) may distinguish this process and serve as new markers of PDLSC differentiation.SignificancePeriodontitis is highly prevalent and can impair PDL and teeth functioning. One of the most promising therapies to periodontitis therapies is PDL regeneration by utilizing PDLSCs. While many obstacles remain to be resolved, the regulation of PDLSC osteogenic differentiation is a main concern. The present study demonstrated the potential clinical value of an ITGA5 priming peptide, which may be utilized in PDL tissue repair and regeneration. The mechanism elucidated in this study would help to fuel its application.

Graphical abstract

image


http://ift.tt/2FSeYoY

Αρχειοθήκη ιστολογίου